SCHEMBL7923329

SCHEMBL7923329

Cc1cc(CCOc2ccc(CC(Nc3ccccc3C(=O)c3ccccc3)C(=O)O)cc2)nn1-c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 1.00
PPARA Q07869 4/20 1.00
PPARD Q03181 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7923335 1.00 PPARG (1.00) PPARGPPARAPPARD
SCHEMBL7926555 0.94 PPARG (0.88) PPARGPPARAPPARD
SCHEMBL7926551 0.94 PPARG (0.88) PPARGPPARAPPARD
SCHEMBL7705701 0.79 PPARG (1.00) PPARGPPARAPPARD
SCHEMBL2785823 0.79 PPARG (1.00) PPARGPPARAPPARD
SCHEMBL2786944 0.78 PPARG (1.00) PPARGPPARA
SCHEMBL2786222 0.77 PPARG (1.00) PPARGPPARA
SCHEMBL2788829 0.77 PPARG (1.00) PPARGPPARAPPARD
SCHEMBL2785233 0.77 PPARG (1.00) PPARGPPARA
Farglitazar SCHEMBL14281408 0.77 PPARG (1.00) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294580-B1 FOR THERAPY AND PROPHYLAXIS OF TYPE II OR NON-INSULIN DEPENDENT DIABETES MELLITUS, HYPERGLYCAEMIA, DYSLIPIDEMIA, TYPE II DIABETES, TYPE I DIABETES, HYPERTRIGLYCERIDEMIA, SYNDROME X, INSULIN RESISTANCE, HEART FAILURE GLAXO WELLCOME INC. 2001-09-25 US disclosed
EP-0888317-B1 SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA GLAXO GROUP LTD (GB) 2001-09-12 EP disclosed